p38 Map kinase inhibitors and methods for using the same
    5.
    发明申请
    p38 Map kinase inhibitors and methods for using the same 失效
    p38地图激酶抑制剂及其使用方法

    公开(公告)号:US20070049598A1

    公开(公告)日:2007-03-01

    申请号:US11509422

    申请日:2006-08-23

    IPC分类号: A61K31/519 C07D487/02

    CPC分类号: C07D487/04

    摘要: Compounds of the formula Ia or Ib: wherein X and Y are N or one of X and Y is N and the other is CRg, and A, D, E, G, W, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the subject compounds and methods of using the compounds for treatment of p38 MAP kinase-mediated diseases.

    摘要翻译: 式Ia或Ib化合物:其中X和Y是N或X和Y中的一个是N,另一个是CR,并且A,D,E,G,W,R SUP > 1,R 2,R 3,R 4和R 5如本文所定义 。 还公开了制备本发明化合物的方法和使用该化合物治疗p38MAP激酶介导的疾病的方法。

    p38 MAP kinase inhibitors and methods for using the same
    6.
    发明申请
    p38 MAP kinase inhibitors and methods for using the same 失效
    p38 MAP激酶抑制剂及其使用方法

    公开(公告)号:US20070049597A1

    公开(公告)日:2007-03-01

    申请号:US11509121

    申请日:2006-08-23

    CPC分类号: C07D487/04

    摘要: Compounds of formula Ia, Ib, Ic, Id, Ie, If, Ig or Ih: wherein X and Y are nitrogen or one of X and Y is nitrogen and the other is CRg, and W, D, E, R4, R5, R6 and R9 are as defined herein. Also disclosed are methods of making the subject compounds and methods of using the compounds in the treatment of p38 MAP kinase-mediated diseases.

    摘要翻译: 式Ia,Ib,Ic,Id,Ie,If,Ig或Ih的化合物:其中X和Y是氮或X和Y中的一个是氮,另一个是CR 9,W, D,E,R 4,R 5,R 6和R 9如本文所定义。 还公开了制备本发明化合物的方法和使用该化合物治疗p38 MAP激酶介导的疾病的方法。

    Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors
    7.
    发明申请
    Substituted 7-aza-quinazoline compounds useful as p38 kinase inhibitors 审中-公开
    可用作p38激酶抑制剂的取代的7-氮杂 - 喹唑啉化合物

    公开(公告)号:US20070135459A1

    公开(公告)日:2007-06-14

    申请号:US11651320

    申请日:2007-01-09

    IPC分类号: A61K31/519 C07D487/02

    CPC分类号: C07D471/04

    摘要: Compounds having the formula (I) or (II), are useful as p38 kinase inhibitors, wherein R is an optionally substituted alkyl, cycloalkyl, or aryl; R6 is hydrogen or lower alkyl; R7 is hydrogen or a non-interfering substituent, and Q is a non-aromatic moiety as defined in the specification.

    摘要翻译: 具有式(I)或(II)的化合物可用作p38激酶抑制剂,其中R是任选取代的烷基,环烷基或芳基; R 6是氢或低级烷基; R 7是氢或非干扰取代基,Q是说明书中定义的非芳族部分。